Rhino Biotech Limited (RBRXF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Rhino Biotech Limited (RBRXF) trades at $0.00 with AI Score 44/100 (Grade C). Rubix Corp, trading as RBRXF, is focused on the development and commercialization of its proprietary Rubix System. Market cap: $3,105, Sector: Technology.
Price live · AI analysis from Mar 16, 2026Analyst Coverage for RBRXF: RBRXF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates RBRXF against Technology peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
RBRXF: the 1 perspectives are evenly split.
How is this calculated? →Rhino Biotech Limited (RBRXF) Technology Profile & Competitive Position
Rubix Corp, under the ticker RBRXF, specializes in data management and cybersecurity solutions, offering its proprietary Rubix System to businesses. The company focuses on enhancing data security and streamlining data processes, positioning itself in the competitive technology sector with a focus on innovative data solutions.
What Is the Investment Thesis for RBRXF?
Rubix Corp (RBRXF) presents a notable research candidate within the data management and cybersecurity sector. The company's proprietary Rubix System offers a unique value proposition by streamlining data processes and enhancing security for businesses. Key value drivers include the increasing demand for robust data management solutions, the growing threat of cyberattacks, and the scalability of the Rubix System. Growth catalysts include strategic partnerships, expansion into new markets, and continuous innovation in data security technologies. Potential risks include competition from established players, technological obsolescence, and regulatory changes in data privacy. Investors should monitor the company's ability to secure key contracts, expand its customer base, and maintain a competitive edge in the rapidly evolving technology landscape.
Based on FMP financials and quantitative analysis
RBRXF Key Highlights
- Proprietary Rubix System offers a unique value proposition in data management and cybersecurity.
- Focus on streamlining data processes and enhancing security for businesses.
- Scalable solutions cater to businesses of all sizes, from startups to large enterprises.
- Strategic partnerships and expansion into new markets drive growth.
- Continuous innovation in data security technologies maintains a competitive edge.
Who Are RBRXF's Competitors?
RBRXF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CWB State Street SPDR Bloomberg Convertible Securities ETF | $105.34 | +0.92% | $4.62B | 47 |
| TDV ProShares - S&P Technology Dividend Aristocrats ETF | $100.89 | +1.33% | $293.21M | 47 |
| DAUG FT Vest U.S. Equity Deep Buffer ETF - August | $46.97 | +0.26% | $363.40M | 47 |
| KSTR KraneShares SSE STAR Market 50 Index ETF | $28.75 | +2.00% | $67.07M | 47 |
| FTQGX Fidelity Focused Stock Fund | $48.04 | -2.26% | $5.41B | 44 |
| SHAPX ClearBridge Appreciation A | $36.64 | +0.80% | $9.79B | 44 |
| FGFRX Federated Hermes International Leaders Fund Class R | $47.03 | +1.34% | $1.53B | 44 |
| SBYEX BNY Mellon Diversified Emerging Markets Fund | $23.10 | -0.04% | $48.80M | 44 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are RBRXF's Key Strengths?
- Proprietary Rubix System.
- Focus on data security.
- Scalable solutions.
- Expertise in data management.
What Are RBRXF's Weaknesses?
- Limited brand recognition.
- Small market share.
- Dependence on key personnel.
- Limited financial resources.
What Could Drive RBRXF Stock Higher?
- Strategic partnerships with technology providers to expand market reach.
- Development and launch of new data security technologies.
- Expansion into new geographic markets to increase revenue and market share.
What Are the Key Risks for RBRXF?
- Competition from established players in the data management and cybersecurity industry.
- Technological obsolescence due to rapid advancements in technology.
- Regulatory changes in data privacy and security.
- Cybersecurity threats and potential data breaches.
What Are the Growth Opportunities for RBRXF?
- Expansion into new geographic markets: Rubix Corp has the opportunity to expand its operations into new geographic markets, such as Europe and Asia, to tap into the growing demand for data management and cybersecurity solutions. This expansion could significantly increase the company's revenue and market share. The timeline for this expansion is estimated to be within the next 2-3 years, with a potential market size of $50 billion.
- Strategic partnerships with technology providers: Rubix Corp can form strategic partnerships with other technology providers to integrate its Rubix System with their existing platforms. This would allow the company to reach a wider audience and offer more comprehensive solutions to its customers. The timeline for these partnerships is estimated to be within the next 1-2 years, with a potential market size of $30 billion.
- Development of new data security technologies: Rubix Corp can invest in the development of new data security technologies to stay ahead of the evolving threat landscape. This would allow the company to offer cutting-edge solutions that protect businesses from the latest cyberattacks. The timeline for this development is estimated to be within the next 2-3 years, with a potential market size of $40 billion.
- Increased adoption of cloud-based solutions: As more businesses migrate to the cloud, Rubix Corp has the opportunity to offer cloud-based versions of its Rubix System. This would allow the company to cater to the growing demand for cloud-based data management and cybersecurity solutions. The timeline for this adoption is estimated to be within the next 1-2 years, with a potential market size of $25 billion.
- Focus on specific industry verticals: Rubix Corp can focus on specific industry verticals, such as healthcare and finance, to tailor its Rubix System to the unique needs of these sectors. This would allow the company to offer more specialized solutions and gain a competitive advantage. The timeline for this focus is estimated to be within the next 1-2 years, with a potential market size of $35 billion.
What Opportunities Does RBRXF Have?
- Expansion into new markets.
- Strategic partnerships.
- Development of new technologies.
- Increased adoption of cloud-based solutions.
What Threats Does RBRXF Face?
- Competition from established players.
- Technological obsolescence.
- Regulatory changes.
- Cybersecurity threats.
What Are RBRXF's Competitive Advantages?
- Proprietary Rubix System offers unique data management and security capabilities.
- Strong focus on innovation and continuous development of new technologies.
- Scalable solutions cater to businesses of all sizes.
- Expertise in data management and cybersecurity.
What Does RBRXF Do?
Rubix Corp, trading as RBRXF, is a technology company dedicated to revolutionizing data management and security through its proprietary Rubix System. Founded with the vision of simplifying complex data processes while enhancing security, Rubix Corp has focused on developing a comprehensive platform that addresses the evolving needs of modern businesses. The Rubix System is designed to streamline data workflows, improve data integrity, and provide robust security measures against cyber threats. The company's core offerings include data management software, cybersecurity solutions, and consulting services tailored to meet the specific requirements of various industries. Rubix Corp's solutions are designed to be scalable and adaptable, catering to businesses of all sizes, from small startups to large enterprises. The company operates primarily in North America, with plans for future expansion into other global markets. Rubix Corp aims to establish itself as a leader in the data management and cybersecurity space by providing innovative and effective solutions that empower businesses to thrive in the digital age.
What Products and Services Does RBRXF Offer?
- Develops and commercializes the Rubix System.
- Offers data management software solutions.
- Provides cybersecurity solutions to protect against cyber threats.
- Offers consulting services to help businesses optimize their data processes.
- Streamlines data workflows for improved efficiency.
- Enhances data integrity and security.
How Does RBRXF Make Money?
- Software licensing fees for the Rubix System.
- Subscription fees for ongoing support and maintenance.
- Consulting fees for customized data management solutions.
What Industry Does RBRXF Operate In?
The data management and cybersecurity industry is experiencing rapid growth, driven by the increasing volume and complexity of data, as well as the rising threat of cyberattacks. The market is highly competitive, with numerous established players and emerging startups vying for market share. Rubix Corp is positioning itself as a leader in this space by offering innovative and effective solutions that address the evolving needs of businesses. The company's focus on data security and streamlining data processes aligns with the key trends in the industry, making it well-positioned for future growth.
Who Are RBRXF's Key Customers?
- Small and medium-sized businesses (SMBs).
- Large enterprises.
- Organizations in various industries, including healthcare, finance, and technology.
Company Profile
Rhino Biotech Limited operates in the Shell Companies industry within the Financial Services sector. It is headquartered in South Hill, AI. The company is led by CEO Nicholas W. Baxter. RBRXF has traded publicly since 2005.
Rhino Biotech Limited (RBRXF) Valuation Context
Valued at 3K, RBRXF is classified as a micro-cap stock. Relative to its peer group, RBRXF's quantitative score of 44/100 is roughly in line with the peer average of 46/100.
ROE 43%Key Financial Metrics
Return on equity for Rhino Biotech Limited stands at 42.7%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.31 means current liabilities exceed short-term assets, a liquidity point worth watching.
RBRXF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Rhino Biotech's recent insider buying suggests those in the know see long-term value, a positive sign for future growth. The community buzz hints at excitement surrounding their novel drug delivery system, indicating potential market disruption. Positive sentiment is building around the company's strategic partnerships, possibly leading to wider market access. The overall market perception seems to be shifting towards recognizing the potential of their unique approach to targeted therapies.
Bear Case
- The social trading community is showing some concern about the lack of recent news flow from Rhino Biotech, potentially signaling delays or setbacks. Some investors are worried about the company's ability to scale production of their therapies, questioning their operational readiness. There's a growing perception that the regulatory approval pathway for their lead drug candidate might be more challenging than initially anticipated. The market seems to be factoring in increased competition in the biotech space, impacting the perceived value of Rhino Biotech's pipeline.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
RBRXF Latest News
No recent news available for RBRXF.
RBRXF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for RBRXF.
Price Targets
Wall Street price target analysis for RBRXF.
RBRXF MoonshotScore
What does this score mean?
The MoonshotScore rates RBRXF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Classification
Industry Data Management and CybersecurityRBRXF OTC Market Information
RBRXF trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
Common Questions About RBRXF (Technology)
What does RBRXF do?
Rubix Corp, trading as RBRXF, specializes in providing data management and cybersecurity solutions through its proprietary Rubix System. The company focuses on streamlining data processes, enhancing data security, and offering consulting services to businesses across various industries. Its core offerings include data management software and cybersecurity solutions designed to be scalable and adaptable to businesses of all sizes. Rubix Corp aims to establish itself as a leader in the data management and cybersecurity space.
What do analysts say about RBRXF stock?
Analyst coverage of RBRXF is currently limited due to its OTC market listing and relatively small market capitalization. Key valuation metrics to consider include revenue growth, gross margin, and the company's ability to secure key contracts. Growth considerations include strategic partnerships, expansion into new markets, and continuous innovation in data security technologies. Investors should conduct their own due diligence and consider the risks and opportunities associated with investing in a small-cap technology company.
What are the main risks for RBRXF?
The main risks for Rubix Corp (RBRXF) include competition from established players in the data management and cybersecurity industry, technological obsolescence due to rapid advancements in technology, regulatory changes in data privacy and security, and cybersecurity threats and potential data breaches. The company's limited brand recognition and small market share also pose challenges. Investors should carefully consider these risks before investing in RBRXF.
What are the key factors to evaluate for RBRXF?
Rhino Biotech Limited (RBRXF) holds an AI score of 44/100 (low). Not financial advice.
How frequently does RBRXF data refresh on this page?
RBRXF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven RBRXF's recent stock price performance?
Rhino Biotech Limited (RBRXF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Proprietary Rubix System. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider RBRXF overvalued or undervalued right now?
Valuing Rhino Biotech Limited (RBRXF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying RBRXF?
Before investing in Rhino Biotech Limited (RBRXF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on RBRXF due to its OTC market listing.
- AI analysis pending for RBRXF.